Waddill William D.'s Form 4 filing
Protagonist Therapeutics, Inc (PTGX) · filed Aug 29, 2025
- Accession no.
- 0001104659-25-085795
- Filed
- Aug 29, 2025
- Trade date
- Aug 27, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $237.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Waddill William D.CIK 0001553338 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | Common Stock | SSaleDisposed | −4,000 | $59.25 | −$237,000 | 9,130 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.